Postmenopausal Osteopenia
12
0
0
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
42%
5 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (12)
The Comparison of Ibandronate and Zoledronic Acid After Denosumab Discontinuation
The Effect of Aerobic Exercise on Bone Turnover Markers in Postmenopausal Patients
OsteoPreP: Food Supplements for Postmenopausal Bone Health
Design and Development of a Novel Food Supplement for Osteoporosis Based on Gut Microbiome Mechanisms
Vitamin K Supplementation in Post-Menopausal Osteopenia
Effects of Kinect-based Virtual Reality Training in Postmenopausal Women With Osteopenia
High Intensity Multi-Modal Exercise Training in Postmenopausal Women
Translation and Cross -Cultural Validation of ECOS-16 Questionnaire in Urdu Language
Prevention of Osteoporosis: Effects of Mini-trampoline Training on the Bone Remodeling
Effect of Calcium and Vitamin D Supplementation With and Without Collagen Peptides in Postmenopausal Women With Osteopenia
A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.
A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia